HomeSMNR • OTCMKTS
add
Semnur Pharmaceuticals Inc
Previous close
$9.00
Year range
$9.00 - $20.00
Market cap
2.07B USD
Avg Volume
31.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 999.00K | -10.00% |
Net income | -999.00K | 10.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.00K | 266.67% |
Total assets | 562.46K | -21.33% |
Total liabilities | 53.53M | -12.65% |
Total equity | -11.14M | — |
Shares outstanding | 160.00M | — |
Price to book | -2.11 | — |
Return on assets | -19.30% | — |
Return on capital | -33.23% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -999.00K | 10.00% |
Cash from operations | 268.00K | 129.74% |
Cash from investing | 8.62M | — |
Cash from financing | -220.00K | -291.30% |
Net change in cash | -2.61K | -635.93% |
Free cash flow | 81.82K | 291.19% |
About
Founded
2013
Website
